SCHEMBL30337162

SCHEMBL30337162

Cn1cc(-c2ccnc(Cl)n2)c2ccc(Cl)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 3/20 0.46
DYRK1B Q9Y463 1/20 0.40
GSK3B P49841 5/20 0.39
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
SCN9A Q15858 1/20 0.37
EGFR P00533 4/20 0.37
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
JAK3 P52333 1/20 0.36
MAT2A P31153 2/20 0.36
MAP3K14 Q99558 1/20 0.36
GSK3A P49840 2/20 0.36
MEN1 O00255 1/20 0.36
RGS12 O14924 1/20 0.36
GMNN O75496 1/20 0.36
USP2 O75604 1/20 0.36
CCNB2 O95067 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28384419 1.00 DYRK1A (0.46) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL28987624 0.89 DYRK1A (0.43) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL30337437 0.89 DYRK1A (0.43) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL19254846 0.88 DYRK1A (0.45) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL17490471 0.88 DYRK1A (0.45) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL30337212 0.88 DYRK1A (0.45) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL17683321 0.86 DYRK1A (0.44) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL30459718 0.86 DYRK1A (0.44) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL30337177 0.84 DYRK1A (0.44) DYRK1ADYRK1BGSK3BMKNK1MKNK2
SCHEMBL28987593 0.84 DYRK1A (0.44) DYRK1ADYRK1BGSK3BMKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed